Internal atrial defibrillation revisited: how low can we go?

Atrial fibrillation (AF) remains the most common and expensive supraventricular arrhythmia. It is the most frequently encountered diagnosis among hospitalized patients and is estimated to cost the U.S. healthcare system more than $5 billion dollars annually [(1)][1]. Although catheter ablation holds